Biopharma Partners Iii Gmbh & Co Beteiligungs Kg Alta files SEC Form 4 disclosures for SUNESIS PHARMACEUTICALS INC. They have made 1 open-market trade across 1 company since 2010, most recently 2010-06-30.
CIK 0001280265
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $3.3M since 2010, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SNSS | 268,883 | $5.0M |
Shares reported on the most recent Form 4, priced at the 2010-07-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SNSS | BUY | 2010-06-30 | 2010-07-02 | $0.28 | $3.3M | -0.0% | +1.2% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.